Literature DB >> 16778294

Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate.

Luke Howard1, Deepa Gopalan, Meryl Griffiths, Ravi Mahadeva.   

Abstract

The differential diagnosis of pulmonary infiltrates after solid-organ transplantation presents a broad differential diagnosis including opportunistic infections and drug-induced lung disease. We report an adult liver transplant recipient who had breathlessness and pulmonary infiltrates following the introduction of sirolimus, and in whom transbronchial biopsy demonstrated a granulomatous interstitial pneumonitis and an organizing pneumonia with a CD4 T-cell infiltrate suggesting a T-helper cell-associated reaction to a processed sirolimus protein complex. Withdrawal of sirolimus produced a rapid clinical and radiologic improvement. This case indicates that with the increasing use of sirolimus, clinicians need to be aware of pulmonary hypersensitivity from this agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778294     DOI: 10.1378/chest.129.6.1718

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.

Authors:  Benjamin A Gartrell; Jian Ying; Shanthi Sivendran; Kenneth M Boucher; Toni K Choueiri; Guru Sonpavde; William K Oh; Neeraj Agarwal; Matthew D Galsky
Journal:  Target Oncol       Date:  2013-07-13       Impact factor: 4.493

2.  A Case of Sirolimus-Induced Interstitial Lung Disease After Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Amey Sonavane; Ashish K Prakash; Arvind Pandey; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

3.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 4.  Non-viral infections in children after renal transplantation.

Authors:  Francesca Mencarelli; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2012-02-09       Impact factor: 3.714

5.  Sirolimus induced granulomatous interstitial pneumonitis.

Authors:  Kamonpun Ussavarungsi; Abdelaziz Elsanjak; Melvin Laski; Rishi Raj; Kenneth Nugent
Journal:  Respir Med Case Rep       Date:  2012-11-07

Review 6.  Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.

Authors:  Patricia Lopez; Sven Kohler; Seema Dimri
Journal:  J Transplant       Date:  2014-12-18

7.  A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.

Authors:  Rei Matsuki; Kenichi Okuda; Akihisa Mitani; Yasuhiro Yamauchi; Goh Tanaka; Haruki Kume; Yukio Homma; Munetoshi Hinata; Akimasa Hayashi; Junji Shibahara; Masashi Fukayama; Takahide Nagase
Journal:  Respir Med Case Rep       Date:  2017-08-11

8.  Zotarolimus-eluting stent-induced hypersensitivity pneumonitis.

Authors:  Hong-Won Shin; Chang-Wook Nam; Hyungseop Kim; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim; Kun-Young Kwon
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

9.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

10.  Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells.

Authors:  Eun Young Kim; Arum Kim; Se Kyu Kim; Hyung Jung Kim; Joon Chang; Chul Min Ahn; Yoon Soo Chang
Journal:  Respir Res       Date:  2014-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.